Consistently, genetic and pharmacological inhibition of USP14 was shown to promote the ubiquitination and degradation of AR and retard the growth of PC cells by arresting them in the G0/G1 phase (Table 2) (Liao et al., 2017). The gene discussed is AR; the disease is pachyonychia congenita.